GLP1R and metabolic dysfunction-associated steatohepatitis: Based on results obtained from clinical trials conducted on the effect of incretin-based drugs on NASH resolution, only liraglutide and semaglutide (two long-acting GLP-1 RAs) were found to be beneficial [106].